Fermentalg SA has raised US$7 million
Fermentalg SA has raised US$7 million to bolster its R&D efforts in order to accelerate the industrialization process of its products.
Founded in 2009, Fermentalg is a biotechnology start-up specializing in the research and production of micro-algae. Its products are designed for applications in healthcare and cosmetics, as well as the agro-food and bio-fuel industries. The company is based in Libourne, France.
Oaklins’ team in France advised Fermentalg SA on this transaction.
Talk to the deal team
Related deals
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn more